Gestational age can predict the need for prophylaxis with surfactant therapy

American Journal of Perinatology

Volumn 15, Issue 4, 1998, Pages 263-267

  Mbuyamba, Madeleine ^a   Holman, Marlene ^a   Kresch, Mitchell J ^a  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

Author keywords

Hyaline membrane disease; Predictive value; Premature infant; Sensitivity; Specificity; Surfactant therapy

Indexed keywords

LUNG SURFACTANT;

ACCURACY; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; GESTATIONAL AGE; HUMAN; HYALINE MEMBRANE DISEASE; INFANT; MAJOR CLINICAL STUDY; PREDICTION; PREMATURITY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; VERY LOW BIRTH WEIGHT;

EID: 0031892920     PISSN: 07351631     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-993939     Document Type: Article

References (22)

1. Fujiwara T, Chida S, Watabe Y, Maeta H, Morita T, Abe T. Artificial surfactant therapy in hyaline-membrane disease. Lancet 1980;55-59
2. The Osiris Collaborative Group. Early versus delayed neonatal administration of a synthetic surfactant - The judgment of OSIRIS. Lancet 1992;340:1363-1369
3. Enhorning G, Shennan A, Possmayer F, Dunn M, Chen CP, Mulligan J. Prevention of neonatal respiratory distress syndrome by tracheal instillation of surfactant: A randomized clinical trial. Pediatrics 1985;76:145-153
4. Kwong MS, Egan EA, Notter RH, Shapiro DL. Double-blind clinical trial of calf lung surfactant extract for the prevention of hyaline membrane disease in extremely premature infants. Pediatrics 1985;76:585-592
5. Merritt TA, Hallman M, Bloom BT, Berry C, Benirschke K, Sahn D, Key T, Edwards D, Jarvenpaa A-L, Pohjavuori M, Kankaanpaa K, Kunnas M, Paatero H, Rapola J, Jaaskelainen J. Prophylactic treatment of very premature infants with human surfactant. New Engl J Med 1986; 315:785-790
6. Soll RF, Hoekstra RE, Fangman JJ, Corbet AJ, Adams JM, James LS, Schulze K, Oh W, Roberts JD, Dorst JP, Kramer SS, Gold AJ, and the Ross Collaborative Surfactant Prevention Study Group. Multicenter trial of single-dose modified bovine surfactant extract (Survanta) for prevention of respiratory distress syndrome. Pediatrics 1990;85: 1092-1102
7. Dunn MS, Shennan AT, Zayack D, Possmayer F. Bovine surfactant replacement therapy in neonates of less than 30 weeks gestation: A randomized controlled trial of prophylaxis versus treatment. Pediatrics 1991;87:377-386
8. Merritt TA, Hallman M, Berry C, Pohjavuori M, Edwards DK, Jaaskelainen J, Grafe MR, Vaucher Y, Wozniak P, Heldt G, Rapola J. Randomized, placebo-controlled trial of human surfactant given at birth versus rescue administration in very low birth weight infants with lung immaturity. J Pediatr 1991;118:581-594
9. Kendig JW, Notter RH, Cox C, Reubens LJ, Davis JM, Maniscalco WM, Sinkin RA, Bartoletti A, Dweck HS, Horgan MJ, Risemberg H, Phelps DL, Shapiro DL. A comparison of surfactant as immediate prophylaxis and as rescue therapy in newborns of less than 30 weeks gestation. New Engl J Med 1991;324:865-871
10. Merritt TA, Soil RF, Hallman M. Overview of exogenous surfactant replacement therapy. J Intensive Care Med 1993; 8:205-228
11. Vaucher YE, Harker L, Merritt TA, Hallman M, Gist K, Bejar R, Heldt GP, Edwards D, Pohjavuori M. Outcome at twelve months of adjusted age in very low birth weight infants with lung immaturity: A randomized, placebo-controlled trial of human surfactant. J Pediatr 1993;122:126-132
12. Kramer MS. Clinical Epidemiology and Biostatistics. New York: Springer-Verlag; 1988:187-219
13. Jeanty P. Fetal biometry. In Fleischer AC, Manning FA, Jeanty P, Romero R, eds. Sonography in Obstetrics and Gynecology, Principles & Practice. Stamford, CT: Appleton & Lange; 1996:137-138
14. Sanders M, Allen M, Alexander GR, Yankowitz J, Graeber J, Johnson TRB, Repka MX. Gestational age assessment in preterm neonates weighing less than 1500 grams. Pediatrics 1991;88:542-546
15. Morley CJ, Greenough A, Miller NG, Bangham AD, Pool J, Wood S, South M, Davis JA, Vyas H. Randomized trial of artificial surfactant (ALEC) given at birth to babies from 23 to 34 weeks gestation. Early Hum Dev 1988;17:41-54
16. Kattwinkel J, Bloom BT, Delmore P, Davis CL, Farrell E, Friss H, Jung AL, King K, Mueller D. Prophylactic administration of calf lung surfactant extract is more effective than early treatment of respiratory distress syndrome in neonates of 29 through 32 weeks gestation. Pediatrics 1993;92:90-98
17. Hellstrom-Westas L, Bell AH, Skov L, Greisen G, Svenningsen NW. Cerebroelectrical depression following surfactant treatment in preterm neonates. Pediatrics 1992;89:643-647
18. Lundstrom KE, Greisen G. Changes in EEG, systemic circulation and blood gas parameters following two or six aliquots of porcine surfactant. Acta Paediatr 1996;85:708-712
19. Kresch MJ, Lin WH, Thrall RS. Surfactant replacement therapy. Thorax 1996;51:1137-1154
20. Dunn MS. Surfactant replacement therapy: Prophylaxis or treatment? Pediatrics 1993;92:148-150
21. Jobe AH. Pulmonary surfactant therapy. N Engl J Med 1993;328:861-868
22. Farrell PM, Avery ME. Hyaline membrane disease. Am Rev Respir Dis 1975;111:657-681